| Classification of adult‐type diffuse gliomas: Impact of the World Health Organization 2021 update BT Whitfield, JT Huse Brain pathology 32 (4), e13062, 2022 | 119 | 2022 |
| Interplay between ATRX and IDH1 mutations governs innate immune responses in diffuse gliomas S Hariharan, BT Whitfield, CJ Pirozzi, MS Waitkus, MC Brown, ML Bowie, ... Nature communications 15 (1), 730, 2024 | 8 | 2024 |
| The Sacred Sites of Houston: A Novel Experiential Course for Undergraduate Medical Education on Religion and Spirituality N King, S Nelson, S Joseph, M Chowdhury, B Whitfield, P Hanjra, LO Lin Journal of religion and health 60 (6), 4500-4520, 2021 | 3 | 2021 |
| G-quadruplex stabilizer CX-5461 effectively combines with radiotherapy to target α-thalassemia/mental retardation X-linked-deficient malignant glioma S Dharmaiah, PB Malgulwar, WE Johnson, BA Chen, V Sharin, ... Neuro-Oncology, noae248, 2024 | | 2024 |
| Identification of Nonfunctional Alternatively Spliced Isoforms of STING in Human Acute Myeloid Leukemia AR Boda, AJ Liu, S Castro-Pando, BT Whitfield, JJ Molldrem, G Al-Atrash, ... Cancer Research Communications 4 (3), 911-918, 2024 | | 2024 |
| CTNI-46. UPFRONT VERSUS DEFERRED TREATMENT IN LOWER GRADE IDH-MUTANT GLIOMAS: A SINGLE-CENTER RETROSPECTIVE ANALYSIS A Patel, B Whitfield, L Ballester, V Puduvalli, C Kamiya-Matsuoka Neuro-Oncology 25 (Suppl 5), v85, 2023 | | 2023 |
| IMMU-15. INTERPLAY BETWEEN ATRXAND IDH1 MUTATIONS GOVERNS INNATE IMMUNE RESPONSES IN DIFFUSE GLIOMAS B Whitfield, S Hariharan, C Pirozzi, M Waitkus, M Brown, M Bowie, D Irvin, ... Neuro-Oncology 25 (Suppl 5), v144, 2023 | | 2023 |
| IMMU-10. EXPLORING THE IMMUNOLOGIC CONSEQUENCES OF ATRX DEFICIENCY IN GLIOMA B Whitfield, J Huse, D Irvin, S Dharmaiah, PB Malgulwar, H Roberts Neuro-Oncology 24 (Suppl 7), vii133, 2022 | | 2022 |
| A multifaceted approach to targeting atrx-deficient glioma PB Malgulwar, S Dharmaiah, B Whitfield, H Roberts, J Ackroyd, J Huse Brain Tumor Research and Treatment 10 (Suppl), 2022 | | 2022 |
| Tumoral p53 mutations differentially mediate poor T-cell infiltration and autologous T-cell killing in preclinical models DA Silverman, E Ashkin, B Whitfield, S Punt, SZ Manrique, Y Wang, ... Cancer Research 79 (13_Supplement), 2372-2372, 2019 | | 2019 |
| G-quadruplex stabilizer CX-5461 effectively combines with radiotherapy to target ATRX-deficient malignant glioma S Dharmaiah, PB Malgulwar, WE Johnson, BA Chen, V Sharin, ... Neuro-oncology, noae248, 0 | | |
